| Literature DB >> 30139338 |
Supannee Promthet1,2, Nopparat Songserm2,3, Somkiattiyos Woradet2,4, Chamsai Pientong5,6, Tipaya Ekalaksananan7,8, Surapon Wiangnon2, Akhtar Ali9.
Abstract
BACKGROUND: Chronic inflammation and repeated infection with Opisthorchis viverrini (O. viverrini) induces intrahepatic cholangiocarcinoma (ICC). Inflammatory cytokines such as interleukin (IL) and tumor necrosis factor (TNF) are substances in the immune system that promote inflammation and causes disease to progress. Genes that help express proinflammatory cytokines can affect an individual's susceptibility to disease, especially in cancer-related chronic inflammation. This study aimed to investigate risk factors for ICC with a focus on opisthorchiasis and polymorphisms of proinflammatory cytokines (IL-1β and TNF-α).Entities:
Keywords: Cholangiocarcinoma; IL-1β; Opisthorchiasis; Polymorphism; TNF-α
Mesh:
Substances:
Year: 2018 PMID: 30139338 PMCID: PMC6108094 DOI: 10.1186/s12885-018-4751-5
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1Polymorphisms in IL-1β C-511T and TNF-α G-308A were analyzed using the polymerase chain reaction with high resolution melting analysis (PCR-HRM)
Odds ratios for intrahepatic cholangiocarcinoma associated with O. viverrini infection intensity, and with IL-1β and TNF-α polymorphisms
| Variables | Cases | Controls | ORa | 95% CI | ORb | 95% CI | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % |
| % | |||||||
| 0.02 | 0.01 | |||||||||
| OD ≤ 0.24 | 32 | 18.8 | 109 | 31.0 | 1.0 | 1.0 | ||||
| OD > 0.24 | 138 | 81.2 | 243 | 69.0 | 2.0 | 1.3–3.1 | 2.1 | 1.2–3.9 | ||
| 0.05 | 0.22 | |||||||||
| CC | 40 | 23.6 | 69 | 19.5 | 1.0 | 1.0 | ||||
| CT | 99 | 58.2 | 187 | 52.8 | 0.9 | 0.6–1.4 | 0.8 | 0.4–1.5 | ||
| TT | 31 | 18.2 | 98 | 27.7 | 0.5 | 0.3–0.9 | 0.4 | 0.2–0.8 | ||
| 0.19 | 0.30 | |||||||||
| GG | 105 | 61.8 | 244 | 68.8 | 1.0 | 1.0 | ||||
| GA | 29 | 17.1 | 58 | 16.3 | 1.1 | 0.7–1.8 | 1.2 | 0.6–2.4 | ||
| AA | 36 | 21.1 | 53 | 14.9 | 1.6 | 1.0–2.6 | 1.7 | 0.9–3.3 | ||
aCrude odds ratios from matched case-control analysis
bAdjusted for smoking (no/yes), alcohol drinking (< 14/≥14 units of alcohol per month), dietary consumption: dish of raw freshwater fish, processed beef, papaya salad (non-consumer, < 1/month & monthly, weekly, daily), total fruits (< 52/≥52 average times per month), and total vegetables (< 35/≥35 average times per month)
General characteristics of intrahepatic cholangiocarcinoma cases and their matched controls
| Variables | Cases | Controls | ||
|---|---|---|---|---|
| % | % | |||
| Sex | ||||
| Female | 92 | 42.0 | 184 | 42.0 |
| Male | 127 | 58.0 | 254 | 58.0 |
| Age at recruitment (years) | ||||
| 30–39 | 7 | 3.2 | 13 | 3.0 |
| 40–49 | 34 | 15.5 | 70 | 16.0 |
| 50–59 | 99 | 45.2 | 199 | 45.4 |
| 60–69 | 79 | 36.1 | 156 | 35.6 |
| Median (min: max) | 57 (31: 69) | 57 (30: 70) | ||
| Education level | ||||
| Illiterate | 26 | 11.9 | 15 | 3.4 |
| Primary school | 185 | 84.5 | 398 | 90.9 |
| Secondary school or higher | 8 | 3.7 | 25 | 5.7 |
| Marital status | ||||
| Single | 4 | 1.8 | 11 | 2.5 |
| Married | 173 | 79.0 | 362 | 82.7 |
| Divorced | 14 | 6.4 | 20 | 4.6 |
| Widowed | 28 | 12.8 | 45 | 10.3 |
| Occupation | ||||
| Farmer | 195 | 89.0 | 399 | 91.1 |
| Government official | 5 | 2.3 | 16 | 3.7 |
| Commercial | 15 | 6.9 | 16 | 3.7 |
| General employee | 4 | 1.8 | 7 | 1.6 |
| Household income per year (Baht) | ||||
| Less than 60,000 (Low) | 213 | 97.3 | 418 | 95.4 |
| 60,001–119,999 (Medium) | 4 | 1.8 | 10 | 2.3 |
| ≥ 120,000 (High) | 2 | 0.9 | 10 | 2.3 |
| Median (min: max) | 10,000 (1200: 120,000) | 10,000 (1000: 360,000) | ||
| Negative | 115 | 62.2 | 230 | 62.2 |
| Positive | 70 | 37.8 | 140 | 37.8 |
Interactions of O. viverrini infection intensity with IL-1β and TNF-α polymorphisms on the risk of intrahepatic cholangiocarcinoma in Thailand
| Polymorphisms | Cases | Controls | ORa | 95% CI | |||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| IgG antibody | 0.52 | ||||||
| CC | OD ≤ 0.24 | 8 | 27 | 1.0 | |||
| CT | OD ≤ 0.24 | 17 | 56 | 0.9 | 0.4–2.5 | 0.90 | |
| TT | OD ≤ 0.24 | 7 | 26 | 0.9 | 0.3–3.1 | 0.88 | |
| CC | OD > 0.24 | 32 | 42 | 2.5 | 0.9–6.6 | 0.06 | |
| CT | OD > 0.24 | 82 | 129 | 2.1 | 0.9–4.9 | 0.10 | |
| TT | OD > 0.24 | 24 | 72 | 1.1 | 0.4–2.8 | 0.89 | |
| IgG antibody | 0.64 | ||||||
| GG | OD ≤ 0.24 | 18 | 73 | 1.0 | |||
| GA | OD ≤ 0.24 | 5 | 20 | 0.9 | 0.3–2.8 | 0.87 | |
| AA | OD ≤ 0.24 | 8 | 14 | 2.2 | 0.8–6.0 | 0.14 | |
| GG | OD > 0.24 | 87 | 169 | 2.1 | 1.2–3.7 | 0.01 | |
| GA | OD > 0.24 | 24 | 38 | 2.4 | 1.1–4.9 | 0.02 | |
| AA | OD > 0.24 | 27 | 37 | 2.8 | 1.4–5.8 | 0.01 |
aCrude odds ratios from matched case-control analysis
bP -value for interaction